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Biography
Dr. Pamela Hinds PhD, RN, FAAN, is the Executive Director of the Department of
Nursing Science, Professional Practice, and Quality, and Professor of Pediatrics at the
George Washington University. She is currently serving on the National Academies of
Sciences, Engineering and Medicine (NASEM) Roundtable on Quality Care for People
with Serious Illness and the NASEM Committee on Childhood Cancers and Disability.
Her expansive research career has focused on the pediatric cancer experience and quality
of life. Dr. Hinds has authored and edited over 400 journal articles and book chapters and
continues to advance the field of pediatric palliative care.
Interview Abstract
Dr. Pamela Hinds begins by identifying some early experiences in her nursing career that
led her towards a career in pediatric palliative care. She recalls some of the challenges of
funding research and reframing some of the discipline’s stigma around child-death from
“physician failure” to a patient and family-informed process of the bio-psycho-social
changes that were happening to the child. Dr. Hinds goes on to describe some of the
successes in pediatric palliative care being the cultivation of the multi-disciplinary then
interdisciplinary team approach as well as the changes in the relationship between
providers and families. Dr Hinds describes the on-going challenges in pediatric palliative
care being credibility, funding, and policy, but she relays her excitement to continue to
help develop this specialty into a vision of patient-first advocacy and patient choice.
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Today is April 19, 2019. I am Bryan Sisk, and I am in St. Louis,
Missouri interviewing Dr. Pamela Hinds over the telephone for the
Pediatric Palliative Care Oral History Project. Dr. Hinds is in
Washington DC. Thank you, Dr. Hinds, for joining me today. To
get started, could you just tell me when did your mind turn toward
pediatric palliative care as a potential career focus?
My first exposure was when I was a nursing student and I was
working with a little boy who had leukemia. At that time, it was a
fatal illness. This was in the 60s and 70s. It was a sobering
experience for me as a very young woman, new to the profession,
to be caring so much about a little one who was not going to
survive. In particular one day, I had missed him. I'd been off the
unit and away from patient care for a couple of days and when I
came back it was very clear to me he had lost ground. He reached
out to me wanting me to hold him and I stepped right into holding
him, but the way I picked him up hurt him.
The thought that I could cause a child pain, oh, was really
horrendous for me. That made me think about dedicating time and
effort towards relieving pain and other symptoms that a child
might have when so, so ill. That got me started and at that time the
philosophy was that you really needed to have experience in
palliative care, and so I did begin. I had time in an emergency
room, nursing time in critical care and then my graduate program I
wanted to focus on how to create an environment of care that
would be gentle for children. Then went on to my doctoral study
some years later, many years later, because I really wanted to look
at hope and how it was that we as clinicians, particularly nurses,
might be able to foster hope in children and adolescents who were
quite, quite ill. That's how I got started.

[00:02:26]
Bryan Sisk:

Pamela Hinds:

[00:03:12]
Bryan Sisk:

When you were starting out, did you find a community of similar
minds on the subject?
No, we really didn't. In fact, people often thought it was hard
enough to be a clinician dealing with children who did not feel
well, but quite hard to be with a child who might not get better.
That was the sense that people had at the time was yeah, but this
child might never get better. No, we didn't find many likeminded
people, and I have to say it made me self-conscious about what I
was choosing to do and what I was looking at. I had to really
question myself about that.
Did other people externally question you?
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Bryan Sisk:
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[00:05:02]
Bryan Sisk:

Pamela Hinds:

[00:06:07]
Bryan Sisk:
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Yes. Family members, friends, professionals all suggested it would
be very likely more worthwhile if I focused my career on children
who were going to recover, children who could become well again.
I think people honestly felt protective of a young person in a new
career that focusing on something so sad might turn the career in a
direction that would be sad too. I think it was a protective effort
based on the real belief that children did not get better.
What was it like to be essentially alone in the early steps?
I think as a young professional, I was doing multiple things at the
same time that all were related to palliative care, but they were not
as—now they would fit the definition of palliative care, but at that
time palliative care was very much defined as end-of-life only. I'm
sure that it would've looked to other people as if I was doing a
blend of activities that were not necessarily moving in the same
direction. Using today's definition, they would have all been seen
as palliative care. We've just developed a broader definition these
days.
Along this journey, when did you first start to find others who
cared about the same work and the same issues?
I think it was in the 1980s and it was very exciting. That became
more pronounced, most definitely in the late 1990s, and then we
really had a widening circle. For me, I had been educated on the
undergraduate and at the graduate level, to really believe in
interprofessional care. For me, I honestly believed, still do, that the
best care is given by a team of diverse disciplines and for me the
best research is that way, then the best—sorry, the best care is that
way then the best research should be that way as well. That helped
me to really seek out interprofessional opportunities and
colleagues. I really think that is the way to live. I think
professionally it's so exciting to live that way.
Who did you learn from or how did you learn when there weren't a
lot of people doing this in the late 60s and early 70s?
I think we learned from people in specialties where there was a
high death rate. For me that was critical care. That was the
emergency room and it was pediatric oncology. You sought
colleagues and we had quite a discussion about taking care of the
suffering child, taking care of yourself very quietly. How would
we do that?
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Then when I finished my doctoral studies in 1985 and then went to
St. Jude Children's Research Hospital where I spent the next two
decades and found a whole host of kindred spirits. That was part of
the excellence of that time period and certainly of those
individuals. I remember creating different studies and always
having a translation piece to that: a piece that would go to the
parents, the piece that would go to our children, and the piece that
would go to clinicians. These were incredibly well received, but
we also did experiential offerings and one was about the meaning
of being a pediatric oncology specialist. One was about having
hope in serious situations and one was about mistake making. I'd
have to say those are examples.
We did grief workshops and other kinds of things, but I would
honestly say to you probably the best attended was mistake
making. I honestly believe that we all feel quite badly about
making a mistake —I just think we're all very conscientious
people. It's horrifying enough to make a mistake - period, but it's
particularly horrifying if it's with a child whose life is ending soon.
You want so badly to do well by that child, and it may be your last
chance to do well by that child. I think that makes it incredibly
more complicated frankly, yeah.
[00:08:40]
Bryan Sisk:

Pamela Hinds:

[00:10:12]
Bryan Sisk
Pamela Hinds:

Speaking of St. Jude, or really any tertiary academic medical
center, a lot of times parents are coming for a cure. St. Jude is the
patron saint of lost causes or last chances. What was your
experience coming into a situation where people might have
viewed death as a failure as opposed to a natural end?
I think I experienced that commonly, even amongst individuals
who were seasoned. I think it was very difficult for a number of
my physician colleagues to see it as anything but a failure.
Concerningly for me, they honestly thought that those of us around
them thought that, too, about them. Truthfully, we never did. It was
very hard to convince physician colleagues that no one saw them
as having failed that child and I can remember having very direct,
very honest conversation with senior physicians at St. Jude
Children's Research Hospital about why we did not see it that way.
How comforting that was for them because they honestly believed
we must have thought less of them.
Have you seen that change over time or has that stayed the same?
I have seen that change over time, but I would say to you quite
honestly, there are still physician colleagues who suffer from that,
and I do mean suffer. Yeah. I know that when for example I had
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done end-of-life studies, palliative care studies, most times we've
had a three-step process confirming eligibility of the family before
we ever approach the family. The first step is to check in with the
attending to make sure that the family could at this point fully
understand that this is a research study that I'm approaching them
about, that they have the right to refuse and that it wouldn't be too
emotionally burdensome for them. Almost always my physician
colleagues have said, "Yes, you could approach this family. They
would meet those criteria."
Also, almost always there would be a gentle smile and the
physician would say, "I know you said you're only studying the
family, but aren't you really studying me, how I do palliative
care?" Truthfully Bryan, we've never done that. That's never been a
part of our studies. I think that even when our physician colleagues
don't say that they suffer from that, they likely do, or they may. I
guess it's at least a risk. Yeah.
[00:11:50]
Bryan Sisk:

Pamela Hinds:

Thinking back to when you were starting out, how do you think
clinicians at that time understood a child suffering?
In my early days of being a nurse, those were the days when you
still had a written medical order that said, "Do not tell the child the
diagnosis. If the child speaks of being worried, comfort the child
and that things are going to get better." We were one of the
earliest, probably, groups that benefitted from the research and
done by Glaser, Strauss and Benoliel about awareness of dying. 1
These pioneers were DRs. Barney Glaser, Anselm Strauss, and
Jeanne Quint Benoliel.
They studied settings where the patients knew that they were
seriously ill, but they did not want it to be spoken of, because they
worried that by speaking of their deteriorating condition, they
would make their families uncomfortable, and they didn't want to
do that. We then benefitted from this research finding in terms of
having the honesty within ourselves and beginning, likely
stumbling at first to have more honesty with our patients and
families, at least when they asked us to do so. That was a real
indication for us to do our best to communicate.

[00:13:31]
Bryan Sisk:

1

In the Awareness of Dying, I've heard that book come up from a
couple of people. Is that a book that you think broadly impacted
pediatric palliative care?

Strauss, A., & Glaser, B. (2005). Awareness of Dying. Aldine Transaction.
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You know it's interesting. It's a great question. I'm not sure that I
know that it broadly affected care, but I know that it trickled down
to my community hospital and then later my academic medical
centers where I worked, because we did change care and care
policies. I guess I can honestly say to you, I don’t know how
broadly that affected care in that decade, but it certainly did affect
the care settings that I practiced in.
Do you think that the clinicians, when they were tending or not
tending to the child suffering, do you think there was a focus on
individual symptoms, or do you think there was a holistic view of
suffering or do you think there is just agnosticism about all of it?
I think that initially we really went after pain. I think we
recognized that children were having pain. One of the early turning
points for us was the work by Jo Eland and she was a real force.
She was a nurse and she studied pain and believed that—in fact
published in the area of the myths about pediatric pain. That helped
to really turn things around, at least in nursing practice, but she
really also worked closely with physician colleagues to say
"children are having pain. It's unbearable and we are under treating
them and you've got to change it." It became a real mantra in the
70s, "We've got to treat child pain."
That was coming from nurses and physicians and it did lead to new
policies, changes in intrusive procedures, and then to the belief that
pain was measurable. In the 1980s we started measuring pain by
child reports and it became, I'm sure as you know, a standard and
now is a JCHO [Joint Commission on Accreditation of Healthcare
Organizations] standard, but if you're not measuring pain, you are
not practicing—you don 't have a best practice. They can give you
a formal recommendation that counts against you with surveys and
in-between surveys. I think it's incredibly exciting to look back and
see where we've come. At the time it seemed very slow, but
definitely coming.

[00:16:27]
Bryan Sisk:

Pamela Hinds:

When you were beginning your work, finishing nursing school and
going through emergency department and ICUs [intensive care
units], what were the biggest challenges for caring for these
suffering children with these serious illnesses?
We had so few tools to make it better. You had to witness the
suffering because we could not give them relief. That meant, not
only did you witness the child suffering; you witnessed the family
suffering. You could do all that you had within you and there are
many things that you can do to try to make a suffering child
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comfortable. Certainly, pharmacologically was a primary effort,
but we also tried to change, oh, my gosh, position, temperature,
lighting, distraction, I mean everything we could think of from a
non-pharmacologic stance to make a child comfortable or to get
reprieve.
Oh, boy, inducing sleep was just such a relief for all of us because
it was so awful to witness the suffering that you just couldn't quiet.
It just didn't stop. I think there was a lot of urgency. You know,
"It's got to be better," was really a mantra. “It's got to be better.”
[00:18:05]
Bryan Sisk:

Pamela Hinds:

Obviously nurses are, at least today, are by the bedside much more
frequently than physicians and I assume back several decades ago,
physicians were probably less tied to computers that didn't exist
and more with patients. But was there a difference between the
awareness of the pain and suffering from the nurse's perspective
and the doctor's perspective?
Yes, and I think it led to some tension, but some suffering was so
overt, no one could miss it and we should always speak to any
level of suffering. I feel that's part of what nursing contributes to a
team through our presence and being able to give firsthand
accounts of what we're seeing. Our other colleagues cannot be
there. That's our job. And so we should be able to give detailed
accounts of what we're seeing that's so believable, that we can
make care better for that child. I think physicians and nurses will
openly talk about and certainly we've documented that we are not
always in synchrony.
I don't think that's unusual and I don't think there's anything
abnormal or wrong with that. I think it's how a team should
function in keeping each other informed enough so that ultimately
we get very close to being at the same place at the same time.
What teams will often report to me is that it is the nurse who gets
to a certain awareness first. It may be because the parent has said
something to the nurse. It may be because of observations, and it is
the nurse then who will say, "Have we had the conversation with
this family yet?"
It is the nurse who keeps bringing that very difficult point up, and
physicians will explain to me that they are not ready at the same
time that a nurse is, and they will say, "No, no, we still have other
things – other treatments - that we are doing, and we really want to
do these other things." I think that creates a tension and I've often
wondered if that tension has a purpose. Instead of us ignoring it—
because it's hard – and certainly it is hard to deal with the tension –
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speaking to it as part of being a team. It's like a tension in a family,
it's hard. But instead of trying to work around it, we should address
it because maybe there are clues about that child's status that are
embedded in that tension, quite frankly.
[00:20:47]
Bryan Sisk:

Pamela Hinds:

[00:21:52]
Bryan Sisk:
Pamela Hinds:

[00:22:39]
Bryan Sisk:

Was there a hesitance of using opioids or stronger medications for
pain in kids back when you were starting out?
Definitely. There was a clear sense that we only had data from
adults that we were taking a huge risk in dosing children with what
was deemed to be an adult drug. There was always the fear that we
would kill the child through the medication because it was an adult
drug and we didn't really know pediatric dosing. We had such fears
about that, and I mean all of us – not at all limited to a single
discipline but a fear shared by all of us. That made it urgent to try
to address some of the very overt suffering that we were
witnessing, and the parent was witnessing, too. We did try dosing
that was previously untried. With adults even we were using
incredibly high doses.
When did that start to change?
I would say the mid-90s was when I recognized that we had really
turned the corner. Before then it was anecdotally unique cases, but
I think by the mid-90s we were routinely using certain drugs
because we did not have the adverse effects that we had feared. We
didn't always get efficacy to the extent that we had wished either,
but we didn't have the adverse outcomes that we had feared.
What was used for pain when there is concern about, I'm assuming,
concern about morphine and things like that?

Pamela Hinds:

There was a concern about morphine, and it was a pronounced
concern, but we did use it. We used it in relatively small doses at
that time. Yeah.

Bryan Sisk:

It was mainly the dosing that was smaller?

Pamela Hinds:

Very much so. Yeah. Of course, now we recognize that children
can tolerate high doses. But we started out at miniscule doses. I
think the disease, like leukemia was so aggressive because our
treatments then were still being refined. We were making definite
progress, protocol by protocol, but I think about the hesitancy that
we had. We had such an aggressive form of disease and such overt
pain, but we were really iteratively finding our way.

[00:23:53]
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Bryan Sisk:

Was there similar concern or hesitance with the toxic
chemotherapies they were given?

Pamela Hinds:

No. I think that's a really interesting question. We recognized that
that was all protocol-driven in pediatric oncology. We felt like we
had a roadmap and having a roadmap really makes a difference, I
believe, in our thinking. What really pleases me is tracking what
we thought we saw as side effects of these new drugs that we were
using in chemotherapy. It led to really great discussions amongst
all members of the team. We nurses would bring forward our
information from infusions as we were the ones who were giving
the infusions in the rooms and we had made the careful
observations. It was a great collaboration between nursing and
medicine. It was really terrific.

[00:25:03]
Bryan Sisk:

Pamela Hinds:

[00:25:58]
Bryan Sisk:

Pamela Hinds:

[00:26:45]
Bryan Sisk:

Pamela Hinds:

What about psychological and social needs? How were those
viewed for the patients and the families back in let's say the early
70s?
I think children were dying fairly quickly then, to be honest with
you, and so we needed to have psychology involved at an earlier
point than typically happened. That really did change with some of
the work by Spinetta, about coping and the advantages of having a
psychologist as a member of the care team. I would say by the 80s
that was considered routine care. They really had to be embedded.
At that time point children were surviving, and it was a very
different prognostic situation.
In terms of the psychological and social, was that something that—
did it seem like most doctors were on board and advocating for that
or more so that most doctors allowed the nurses and psychologists
to pursue that? What was your sense of their view about that?
I really saw my physician colleagues welcoming that. I didn't—
sometimes you would have another member of the team, like a
nurse, make the suggestion, but I never saw—well, I rarely saw an
attending refuse or say something that was negative. Very rarely.
Then for these children, were they involved in their own care at
that time?
Yes. Now this varied. [laughs] Quite frankly, it varied.
Increasingly children were asking us questions, the nurses around
the bedside, and increasingly waiting until their parent left the
room to have a discussion. Yes, I would say to you that children
were getting very involved and it really thrilled us as nurses about
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that. I think there was also a societal shift of recognizing the
importance of the child’s voice. Children were being invited into
other kinds of conversations too.
They were being recognized as more articulate and in research we
were inviting children to rate symptoms, and to talk to us about
their quality of life in the 1980s. If they could articulate about
those topics, our reasoning was they could also articulate about
end-of-life decision-making. A lot of that was really tied to our
comfort in pursuing palliative and end-of-life research by seeking
the child voice, became more possible because we had previously
included them in symptom studies.
[00:28:21]
Bryan Sisk:

Pamela Hinds:

[00:28:46]
Bryan Sisk:

Pamela Hinds:

Do you think that societal shift was around the 80s at the same
time or when do you think that occurred?
I do think it was around there. I do. I think the 80s and 90s were
really quite significant family structure shifts and family
inclusiveness and children had voices that they had not had before.
When in your career did you understand that the things you were
interested in were being called pediatric palliative care or
pediatric—when did that phrasing and that kind of
conceptualization of the things you were doing come to your
mind?
Boy, it's a good question. Do I know? [laughs] Certainly, in the
70s it was being used, but primarily for end of life. I went to St.
Jude in '85 and was very involved in palliative and end of life care
from the beginning. But it was in the 2000s when I approached
hospital leadership about creating a palliative care service and
defined it using the academy's definition ‘from the point of
diagnosis of a very serious or life threatening illness’. This was not
the first time that someone had approached the hospital leadership
about creating this kind of service, but I think our timing was
better because we had done research in the area and that was the
dominant culture there.
If you could get external funding for an area of science, must be it
was worth doing! We had had some very good luck in getting that
funding. Then I got appointed to the Institute of Medicine's
committee on Children Dying in America and that really—and I
had a very supportive physician colleague, Dr. Joe Mirro who was
the chief medical officer at St. Jude and I will always credit him
with having supported my participation in that committee work. I
said to him, "You know, if I accept this invitation, I'm going to
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have to indicate to them that we do not have a palliative care
service." He said, "Oh, but do it anyhow." That experience plus
others really helped us to create that service and to begin research
in this area, and that included end-of -life decision-making from
the child's perspective, including from the child that was dying. It
was really very exciting; exciting days.
[00:31:24]
Bryan Sisk:

Pamela Hinds:

[00:33:06]
Bryan Sisk:

Pamela Hinds:

[00:33:25]
Bryan Sisk:

Pamela Hinds:

2

In thinking back to end of life, another question I had about your
earlier experiences, what was the presence of the clinical team
members around the end of life? Were there people around or
where they avoidant? Can you tell me a little more about that?
I think initially it wasn't so much avoidance, it was trying to be
thoughtful of the family. The assumption was that we should leave
them as much to themselves as we could and many of these
children, many, died in the hospital. This followed of course, Ida
Martinson's groundbreaking work 2 where she clearly taught us that
children could die at home, that it was very acceptable to families,
physicians and nurses involved in that model. Others since then,
building on that work have taught us about the cost of that care. I
would say initially it was probably just uncomfortableness, but
primarily wanting to do what the families might want us to do. We
often did that without asking the family. It was an assumption and
it was only later that we really started asking, "What would you
like? How can we best do this for you?" I think it took us a while
to find our way. I think instead of talking about something, we
primarily thought, "How would my family want this done?" We
got very careful, truthful.
Have you seen that change over time, or has it changed in some
pockets and not in others?
I think it's definitely changed. We talk much more openly with
each other as a team and we will ask families, how would you like
this to be? I think it's very different.
As you were getting your experience in critical care and
emergency medicine to try to get the skills you needed to do this
career, what were the biggest challenges you faced as you tried to
build this palliative care career?
Credibility amongst other services, soothing fears that a palliative
care service would step in and interfere with their relationship long
established with a child in a family. I think we underestimate that

Martinson, I., Armstrong, G.D., Geis, D.P., Anglim, M.A., Gronseth, E.C., MacInnis, H., Kersey, J.H.,
Nesbut, M.E. Home care for children dying of cancer. Pediatrics, Vol 62(1), 106-113.
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anxiety in our good colleagues. That continues to be a real anxiety.
Are we going to sever, replace, someone who's really had a very
important relationship with the family already? I think then for me
additionally was the challenge of finding research funding for this
kind of work because we knew that we didn't know what we
needed to know and that we needed to do research to learn
firsthand from these children and their parents and each other
about what we could do.
I think professional courage is part of this story for all of us finding
our way. Being confident that if in fact we erred, and you'll always
hear us talk about not wanting to do harm. If we erred, that we had
the skills and the relationship to correct what we might've done and
start again.
[00:35:20]
Bryan Sisk:

Pamela Hinds:

[00:36:30]
Bryan Sisk:

Pamela Hinds:

[00:37:21]
Bryan Sisk:

3

How do you think these developing palliative care teams, how do
you think they were initially viewed by the pediatric patients
themselves?
With caution. I think they liked the people on the team, but it was
another team. It was clear it was a different focused team. I think,
and I mean that from the family perspective primarily, just
cautious like, "What is this?" But I have seen stellar relationships
evolve between a palliative care team and another specialty care
team and between the palliative care team, the family, including all
members. It has been an evolution and a lot of it is being able to
self-describe what we do, answering to uneasiness to others, and
being very mindful about what our presence does to the presence
of others.
You had mentioned research funding which is I guess for everyone
is an ongoing challenge, but probably was a lot worse back then.
[laughs] It was. There was no strong interest at NIH [National
Institute of Health] initially in this kind of research. Our early
funding was from oh, gosh, The Project on Death in America. 3
Quite a name, and this philanthropist really did get several of us
started, Joanne Hilden, Joanne Wolf and I were all funded through
this mechanism. From there I went on to NIH for funding, but I
credit that philanthropist in getting us all started.
When did NIH start to develop an appetite for this type of
research?

Soros, G., Foley, K. Project on Death in America. Open Society Institute. New York.
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I guess it again depends upon how we define palliative care,
because certainly there was pain research funded by NIH for
decades. Very notably in the previous decade NIH took note of the
importance of palliative care in the broadest sense and including
end-of-life care and that they should be involved in funding
research. The mandate went out for this kind of research to be
funded. The home for that was of course the National Institute of
Nursing Research and the office is there, but other institute can cofund this kind of research. What's good about having an office
within an institute is that funding mechanisms are coming forth as
well visionary thinking and planning.
They've had new ones this year, several in 2018, 2017, 2016,
further back. It's really significant for us that the NIH has this
office. Now it frustrates people because the overall funding of
something that is overtly labeled "palliative" and "end-of-life
research," is a very small percentage of the overall budget. That’s
factual. But if you look at the broader definition of palliative care,
a fair amount more would be noted. It's not by any means
anywhere near the amount of dollars being put into cure-oriented
research, but it does have a foothold and it has very passionate and
dedicated individuals who are leading that office.

[00:39:20]
Bryan Sisk:

From your perspective, what drove the development of pediatric
palliative care as its own specialty?

Pamela Hinds:

Need. I think there was clearly a need that was recognized, had its
own body of knowledge and it had passionate and committed
people who wanted to make that their career. I would say I think
need was really the driving force.

Bryan Sisk:

Who do you think was recognizing that need?

Pamela Hinds:

Families initially, and so I think part of the reason that Jo Eland
was so successful in the 70s, and Ida Martinson in the 70s and 80s,
was that they aligned with parents, parents whose children had
suffered and died. They were determined not to have this happen
again. It isn't just those two individuals, but what was so
significant of course was that they aligned so well with a care
recipient or consumer. I would say I believe that when a health
care professional aligns well with families, they're unbeatable.
They're absolutely unbeatable. Both of them took these models
internationally and that also influenced how far we could go with
this work.

[00:40:55]
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Bryan Sisk:

Then along that path, what do you think were the biggest
challenges as it was developing into a specialty?

Pamela Hinds:

I would go back again to credibility and the fear of severing or
interfering with relationships with others, building that body of
knowledge. Publishing original research took a while. When we
first did the Institute of Medicine's 2003 report, 4 so we started that
in 2001, 5 there was very little research and we were citing what's
considered classic and older work. A lot of that book was
anecdotal, experiential report, national statistics on children, the
causes of death, but not much research on symptom management
and the actual dying.
Then fast forward to that 2015 report, 6 as we were bringing in
evidence, two of the leaders for that working committee said "You
probably want to have a special section called "Other" and have all
the pediatric data there." I said, "No, no, we are way beyond that.
We have enough data now for every section to reflect pediatrics."
That was a huge step forward for us to be able to say that. My hope
is that we will have another report in another seven to ten years
and it will be so substantial. It may be a freestanding pediatric
report based on evidence.

[00:42:47]
Bryan Sisk:
Pamela Hinds:

Wow, that would be a dream.
It would be, yes. It really would be. You said something really
significant today in our previous conversation about discourse,
needing to have discourse. I would support you in that statement,
but what I would say to you is what we know is that as palliative
care specialists, we are not as skilled with public discourse as
people such as a Sarah Palin, who really grabbed the public
attention so thoroughly, so incorrectly, that the Affordable Care
Act had to drop the sections related to hospice and palliative care.
She did it by using that phrase, "death panel." She was absolutely
wrong. It was declared the greatest lie of the year, but very
effectively destroyed that part of the bill.
We in turn were not effective in countering her approach. We've
got to learn to do that. We've got to have public discourse about
dying, about suffering and we've got to be able to do it in a way

4

Long, K. (2003). The Institute of Medicine Report: Health Professions Education: A Bridge to Quality.
National Institutes of Medicine. Washington, D.C.: National Academy Press.
5
Institute of Medicine (2001). Crossing the quality chasm: A new health system for the 21st century.
Washington, D.C.: National Academy Press.
6
Institute of Medicine (2015). Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk.
Washington, D.C.: National Academy Press.
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that our voice can be heard above a politicians voice or any other
person's voice that is frankly, blatantly incorrect and alarmist. We
have not yet mastered that.
Bryan Sisk:

I agree. That's a pervasive problem for really all of science.

Pamela Hinds:
[00:44:39]
Bryan Sisk:

I would agree with you absolutely.

Pamela Hinds:

Oh, I think we owe them a lot. [laughs] I'm very grateful to them.
In fact, I often think that we ought not to try to distinguish
ourselves too, too much and we always say a child's not a little
adult. Of course, that's true, but I also think we can learn much
from our adult follies and given that we have such a much-reduced
population. We would possibility prevent ourselves from learning
something if we didn't join forces with them in some ways. Better
for us to really test what’s different and what's the same in children
adults than just a claim that there's no similarity, I think.

[00:45:34]
Bryan Sisk:

Pamela Hinds:

[00:46:17]
Bryan Sisk:

Pamela Hinds:

How much do you think the adult hospice and palliative movement
affected the development of pediatric palliative care?

Were there any negative influences? I guess any problems or
barriers that were created from the adult hospice movement on the
development of pediatric palliative care.
Really none that I know of, but I would say they were more
advanced than we were. They had a head start and so we do have
to compete funding wise when I think about NIH. Yeah, so it's fair
I guess to say that there is that to be said. I've never sensed
interference or competition.
When you look over your career, what do you think have been the
biggest changes in the care that we provide for these suffering
children?
Oh, gosh. I'm thinking of it in several categories. We really do see
it as family centered care and so all family members are much
more intricately involved with the care than ever before, so that's a
real advance. We really have advanced through technology with
care intervention. I know I mentioned terminal sedation to you in a
comment earlier today. That's clearly an act out of desperation, but
it wasn't an option.
There was no such option to really go after what is eluding us, and
I don't think that's the greatest example of technology, believe me,
but there are repeated examples of where we now recognize and
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intervene with symptoms broadly stated. It isn't just pain. We're
going after something that we would've said decades ago was
unimportant, that's fatigue. What can we do to help a child who's
overwhelmingly experiencing fatigue and can no longer achieve
developmental milestones? We think about that now and I don't
think—I know we didn’t think about that years ago. We were not
thinking like that.
I think the other category where we are very different is
communication. No longer do we have those orders written, "Do
not tell the diagnosis, do not speak." We know that we wouldn't do
that. That we would be responsive and listen well and honor the
child's voice, so I think it's quite different over the decades.
[00:48:19]
Bryan Sisk:

Pamela Hinds:

[00:49:15]
Bryan Sisk:

Pamela Hinds:

[00:50:27]
Bryan Sisk:
Pamela Hinds:

You have a voluminous body of work, so how do you think your
work contributed to these changes?
Oh, now that I'm probably not going to be so good about. I really
don't know. I'm not sure Bryan. It's a fair question, probably one
that I don't reflect on because I think instead of how much we have
left to do. I'm excited about all that we have left to do. We have
quite a bit. It's good that you make us look backwards and I often
say that here. We should look back because if we don't, we won't
see how far we've come. Looking back sometimes gives you
clarity on what you've got to do next. I guess I should think about
that a little bit more than I have.
What do you think, looking at the field where it sits now, what do
you think are the biggest challenges that we face right now?
I think credibility remains a challenge. Building the field both with
knowledge and numbers is essential. Research funding you will
always hear us say is so, so needed. It is, but I feel as a young field,
we have more going for us than many other fields and part of that
is the interprofessional approach. It's well-established in this
specialty are and there are older specialties where it is not, and I
wish it could be because it makes such a difference.
What do you think the field really needs to grow?
I think technology will always remain a need for us. I think the
work with communication is essential. I feel very good about the
focus made on both. I think policy is gonna be essential for us and
though not a ‘first thought’ for us, if we're going to have public
discourse about what is needed, we've got to be better at public
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discourse. That means being well prepped for it and seeking
opportunities to engage the public in these kinds of discussions.
[00:51:23]
Bryan Sisk:
Pamela Hinds:

[00:52:22]
Bryan Sisk:

Pamela Hinds:

[00:53:44]
Bryan Sisk:

What do you think are the strongest areas of the field currently?
I do think collaboration across settings is very strong. I do think
the relationship between the clinical investigators and the Office of
End of Life Research is very strong and waiting to be built more.
We have such champions there and they really just need our
support in order to do that. I think I would go with policy as where
I'm sure we've got more work to do.
Lastly, I just want you to dream aloud for me. If budget and
politics and Sarah Palin's, and all these other things were no
obstacle, what would you want care for these children to look like
in another ten years?
I would want for these children to be able to choose the location of
their care and that we could fully meet their choice. They know
where they thrive, and there are some children who choose hospital
care. I would like that to be a choice. I would like our care to be so
present, so effective that our families will not feel alone. I would
like our care to be so effective, for the time that we have them with
us that they never forget that, that they know that we believe in
them, that they were good parents, and that they did something
really remarkable for that child.
Beautiful. Well, that's the end of my questions. Is there anything
else about this history that you wanna tell me about or you think
that I might have missed over?

Pamela Hinds:

You know, the only thing that I might mention is that along the
way, different disciplines, including nursing, created position
papers, standards of practice, scope of practice, all related to
palliative and end of life. I think that's so excellent that the
disciplines formalize their support in ways that are meant to guide
practice. It's the official sanctioning and so I think that's important
to note and some of those position papers were very much about
managing pain and the ethics of intervention. Certainly, for
nursing, we began those in the 2000s, early 2000s. I don't know the
start date for similar kinds of things in medicine, but I think the
American Academy of Pediatrics has something very similar as I
go over their position statements. I think that's worth mentioning.

Bryan Sisk:

Anything else?
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That's perfect and I so appreciate you going after this. Keep right
on going Bryan. You're doing important work.
[End of Audio]

